Literature DB >> 29981054

Effects of Prion Protein on Aβ42 and Pyroglutamate-Modified AβpΕ3-42 Oligomerization and Toxicity.

Katiuscia Pagano1, Denise Galante2, Cristina D'Arrigo2, Alessandro Corsaro3, Mario Nizzari3, Tullio Florio3, Henriette Molinari1, Simona Tomaselli4, Laura Ragona5.   

Abstract

Soluble Aβ oligomers are widely recognized as the toxic forms responsible for triggering AD, and Aβ receptors are hypothesized to represent the first step in a neuronal cascade leading to dementia. Cellular prion protein (PrP) has been reported as a high-affinity binder of Aβ oligomers. The interactions of PrP with both Aβ42 and the highly toxic N-truncated pyroglutamylated species (AβpE3-42) are here investigated, at a molecular level, by means of ThT fluorescence, NMR and TEM. We demonstrate that soluble PrP binds both Aβ42 and AβpE3-42, preferentially interacting with oligomeric species and delaying fibril formation. Residue level analysis of Aβ42 oligomerization process reveals, for the first time, that PrP is able to differently interact with the forming oligomers, depending on the aggregation state of the starting Aβ42 sample. A distinct behavior is observed for Aβ42 1-30 region and C-terminal residues, suggesting that PrP protects Aβ42 N-tail from entangling on the mature NMR-invisible fibril, consistent with the hypothesis that Aβ42 N-tail is the locus of interaction with PrP. PrP/AβpE3-42 interactions are here reported for the first time. All interaction data are validated and complemented by cellular tests performed on Wt and PrP-silenced neuronal cell lines, clearly showing PrP dependent Aβ oligomer cell internalization and toxicity. The ability of soluble PrP to compete with membrane-anchored PrP for binding to Aβ oligomers bears relevance for studies of druggable pathways.

Entities:  

Keywords:  Alzheimer disease; Amyloid beta peptides; Cell internalization; Cellular prion protein; Interaction studies; Nuclear magnetic resonance

Mesh:

Substances:

Year:  2018        PMID: 29981054     DOI: 10.1007/s12035-018-1202-x

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  6 in total

Review 1.  The multiple functions of PrPC in physiological, cancer, and neurodegenerative contexts.

Authors:  Izabella Grimaldi; Felipe Saceanu Leser; José Marcos Janeiro; Bárbara Gomes da Rosa; Ana Clara Campanelli; Luciana Romão; Flavia Regina Souza Lima
Journal:  J Mol Med (Berl)       Date:  2022-09-03       Impact factor: 5.606

2.  Prion Protein Antagonists Rescue Alzheimer's Amyloid-β-Related Cognitive Deficits.

Authors:  Abhay P Sagare; Melanie D Sweeney; Amy R Nelson; Zhen Zhao; Berislav V Zlokovic
Journal:  Trends Mol Med       Date:  2019-01-17       Impact factor: 11.951

Review 3.  The Toxicity and Polymorphism of β-Amyloid Oligomers.

Authors:  Ya-Ru Huang; Rui-Tian Liu
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

Review 4.  Natural Compounds as Inhibitors of Aβ Peptide Aggregation: Chemical Requirements and Molecular Mechanisms.

Authors:  Katiuscia Pagano; Simona Tomaselli; Henriette Molinari; Laura Ragona
Journal:  Front Neurosci       Date:  2020-12-22       Impact factor: 4.677

5.  Anti-PrP monoclonal antibody as a novel treatment for neurogenesis in mouse model of Alzheimer's disease.

Authors:  Ruolin Li; Ming Ren; Yingxin Yu
Journal:  Brain Behav       Date:  2021-10-21       Impact factor: 2.708

Review 6.  Emerging Role of Cellular Prion Protein in the Maintenance and Expansion of Glioma Stem Cells.

Authors:  Stefano Thellung; Alessandro Corsaro; Alessia G Bosio; Martina Zambito; Federica Barbieri; Michele Mazzanti; Tullio Florio
Journal:  Cells       Date:  2019-11-18       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.